These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 20354660)

  • 1. Radiotherapy for oligometastatic disease in patients with spinal cord compression (MSCC) from relatively radioresistant tumors.
    Freundt K; Meyners T; Bajrovic A; Basic H; Karstens JH; Adamietz IA; Rudat V; Schild SE; Dunst J; Rades D
    Strahlenther Onkol; 2010 Apr; 186(4):218-23. PubMed ID: 20354660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose escalation for metastatic spinal cord compression in patients with relatively radioresistant tumors.
    Rades D; Freundt K; Meyners T; Bajrovic A; Basic H; Karstens JH; Adamietz IA; Wildfang I; Rudat V; Schild SE; Dunst J
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1492-7. PubMed ID: 20579816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose escalation of radiotherapy for metastatic spinal cord compression (MSCC) in patients with relatively favorable survival prognosis.
    Rades D; Panzner A; Rudat V; Karstens JH; Schild SE
    Strahlenther Onkol; 2011 Nov; 187(11):729-35. PubMed ID: 22037654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Escalation of radiation dose beyond 30 Gy in 10 fractions for metastatic spinal cord compression.
    Rades D; Karstens JH; Hoskin PJ; Rudat V; Veninga T; Schild SE; Dunst J
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):525-31. PubMed ID: 17141977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgery followed by radiotherapy versus radiotherapy alone for metastatic spinal cord compression from unfavorable tumors.
    Rades D; Huttenlocher S; Bajrovic A; Karstens JH; Adamietz IA; Kazic N; Rudat V; Schild SE
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e861-8. PubMed ID: 21277114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new prognostic factor for the survival of patients with renal cell carcinoma developing metastatic spinal cord compression.
    Rades D; Weber A; Bartscht T; Bajrovic A; Karstens JH; Schild SE
    Strahlenther Onkol; 2014 Jul; 190(7):667-70. PubMed ID: 24535650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A matched-pair analysis comparing 5x4 Gy and 10x3 Gy for metastatic spinal cord compression (MSCC) in patients with favorable survival prognoses.
    Rades D; Huttenlocher S; Veninga T; Bajrovic A; Bremer M; Rudat V; Schild SE
    Radiat Oncol; 2015 Apr; 10():90. PubMed ID: 25889036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is short-course radiotherapy with high doses per fraction the appropriate regimen for metastatic spinal cord compression in colorectal cancer patients?
    Rades D; Dahm-Daphi J; Rudat V; Schulte R; Stalpers LJ; Veninga T; Hoskin PJ
    Strahlenther Onkol; 2006 Dec; 182(12):708-12. PubMed ID: 17149577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors and a survival score for patients with metastatic spinal cord compression from colorectal cancer.
    Rades D; Douglas S; Huttenlocher S; Veninga T; Bajrovic A; Rudat V; Schild SE
    Strahlenther Onkol; 2012 Dec; 188(12):1114-8. PubMed ID: 23111468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic spinal cord compression in non-small cell lung cancer patients. Prognostic factors in a series of 356 patients.
    Rades D; Douglas S; Veninga T; Bajrovic A; Stalpers LJ; Hoskin PJ; Rudat V; Schild SE
    Strahlenther Onkol; 2012 Jun; 188(6):472-6. PubMed ID: 22361746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors in a series of 504 breast cancer patients with metastatic spinal cord compression.
    Rades D; Douglas S; Veninga T; Stalpers LJ; Bajrovic A; Rudat V; Schild SE
    Strahlenther Onkol; 2012 Apr; 188(4):340-5. PubMed ID: 22354333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional outcome and survival after radiotherapy of metastatic spinal cord compression in patients with cancer of unknown primary.
    Rades D; Fehlauer F; Veninga T; Stalpers LJ; Basic H; Hoskin PJ; Rudat V; Karstens JH; Schild SE; Dunst J
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):532-7. PubMed ID: 17084539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression.
    Rades D; Fehlauer F; Schulte R; Veninga T; Stalpers LJ; Basic H; Bajrovic A; Hoskin PJ; Tribius S; Wildfang I; Rudat V; Engenhart-Cabilic R; Karstens JH; Alberti W; Dunst J; Schild SE
    J Clin Oncol; 2006 Jul; 24(21):3388-93. PubMed ID: 16849752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-course radiotherapy (RT) for metastatic spinal cord compression (MSCC) due to renal cell carcinoma: results of a retrospective multi-center study.
    Rades D; Walz J; Stalpers LJ; Veninga T; Schulte R; Obralic N; Wildfang I; Engenhart-Cabilic R; Hoskin PJ; Schild SE
    Eur Urol; 2006 May; 49(5):846-52; discussion 852. PubMed ID: 16442206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotherapy of metastatic spinal cord compression in very elderly patients.
    Rades D; Hoskin PJ; Karstens JH; Rudat V; Veninga T; Stalpers LJ; Schild SE; Dunst J
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):256-63. PubMed ID: 17189074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A validated survival score for breast cancer patients with metastatic spinal cord compression.
    Rades D; Douglas S; Schild SE
    Strahlenther Onkol; 2013 Jan; 189(1):41-6. PubMed ID: 23138773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer patients with metastatic spinal cord compression. Number of extraspinal organs involved by metastases influences survival.
    Weber A; Bartscht T; Karstens JH; Schild SE; Rades D
    Strahlenther Onkol; 2014 Mar; 190(3):283-6. PubMed ID: 24264465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors predicting functional outcomes, recurrence-free survival, and overall survival after radiotherapy for metastatic spinal cord compression in breast cancer patients.
    Rades D; Veninga T; Stalpers LJ; Schulte R; Hoskin PJ; Poortmans P; Schild SE; Rudat V
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):182-8. PubMed ID: 16198069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the overall treatment time of radiotherapy with 10 × 3 Gy for outcomes in patients with metastatic spinal cord compression.
    Rades D; Janssen S; Conde-Moreno AJ; Cacicedo J; Metz M; Veninga T; Segedin B; Rudat V; Schild SE
    J Med Imaging Radiat Oncol; 2017 Jun; 61(3):388-393. PubMed ID: 27804231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors for different outcomes in patients with metastatic spinal cord compression from cancer of unknown primary.
    Douglas S; Huttenlocher S; Bajrovic A; Rudat V; Schild SE; Rades D
    BMC Cancer; 2012 Jun; 12():261. PubMed ID: 22720880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.